DrugPatentWatch Database Preview
Ergot Derivative Drug Class List
» See Plans and Pricing
Drugs in Drug Class: Ergot Derivative
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Us Pharms Holdings I | PARLODEL | bromocriptine mesylate | CAPSULE;ORAL | 017962-002 | Mar 1, 1982 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Us Pharms Holdings I | PARLODEL | bromocriptine mesylate | TABLET;ORAL | 017962-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Breckenridge | METHYLERGONOVINE MALEATE | methylergonovine maleate | INJECTABLE;INJECTION | 040889-001 | Sep 13, 2010 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Novel Labs Inc | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 091577-001 | May 2, 2011 | AB | RX | No | Yes | Start Trial | Start Trial | Start Trial | |||
| Granules Pharms | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 210424-001 | May 15, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Teva Pharms Usa | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 211455-001 | Mar 20, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
